Summary statement: Utility of molecular marker testing in thyroid cancer

Linwah Yip, Electron Kebebew, Mira Milas, Sally E. Carty, Thomas J. Fahey, Sareh Parangi, Martha A. Zeiger, Yuri E. Nikiforov

Research output: Contribution to journalArticlepeer-review

Abstract

The use of molecular markers for thyroid cancer diagnosis, prognosis, and surveillance have been an exciting area of study and change. Recent investigative focus on promising new markers will very likely lead to improvements in the diagnostic utility of fine needle aspiration biopsy (FNAB) in predicting malignancy, as well as provide more accurate prognostic information pre- and postoperatively. The 2010 Annual Meeting of the American Association for Endocrine Surgeons featured a symposium dedicated to molecular marker testing in thyroid cancer and its potential clinical applicability.

Original languageEnglish (US)
Pages (from-to)1313-1315
Number of pages3
JournalSurgery
Volume148
Issue number6
DOIs
StatePublished - Dec 1 2010

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Summary statement: Utility of molecular marker testing in thyroid cancer'. Together they form a unique fingerprint.

Cite this